# OncoResponse funding: rounds and investors > OncoResponse has raised $44M across 3 rounds since 2016. Investors include GreatPoint Ventures, Canaan and ARCH Venture Partners. Every round with its source. Source: https://millionrounds.com/company/oncoresponse (Millionrounds; every figure on the page links to its filing or article) United States · [Series D startup](https://millionrounds.com/companies) # Who invested in *OncoResponse* 3 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Pharma Funding summary Updated 26 Oct 2026 **$44M** raised across 3 rounds since 2016, from 3 sources **$7.0M** Series A **$23M** Series A **$14M** Series D - **Latest round:** Series D, $14M May 2023 - **Biggest round:** $23M Series A · Mar 2017 - **Investors:** 11 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2017 2018 2019 2020 2021 2022 2023 **$7.0M** Series A **$23M** Series A **$14M** Series D - **First round:** Series A, $7.0M - **Biggest round:** $23M - **Usual gap between rounds:** 6.2 years ## The rounds - **May 2023** Series D **$14M** *2 new* *2 returning* [Canaan](https://millionrounds.com/fund/canaan-partners) [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) [Redmile Group](https://millionrounds.com/fund/redmile-group) [GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures) Source recorded SEC filing: $14M sold, first sale May 2023 - **Mar 2017** Series A **$23M** *8 new* *1 returning* [Canaan](https://millionrounds.com/fund/canaan-partners) [GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures) [Arch](https://millionrounds.com/fund/arch) [Alexandria Real Estate](https://millionrounds.com/fund/alexandria-real-estate) [Helsinn](https://millionrounds.com/fund/helsinn) [Baxalta](https://millionrounds.com/fund/baxalta-ventures) HT Family Office MD Anderson Marsh Rice University Reported by FinSMEs SEC filing: $29M sold, first sale Sept 2015 - **Oct 2016** Series A **$7.0M** *1 new* [GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures) Reported by FinSMEs ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2016 **Series A** 2017 **Series D** 2023 [GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures) [Canaan](https://millionrounds.com/fund/canaan-partners) [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) [Redmile Group](https://millionrounds.com/fund/redmile-group) [Arch](https://millionrounds.com/fund/arch) [Alexandria Real Estate](https://millionrounds.com/fund/alexandria-real-estate) [Helsinn](https://millionrounds.com/fund/helsinn) [Baxalta](https://millionrounds.com/fund/baxalta-ventures) HT Family Office Marsh Rice University ## Everyone who backed them [GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures) VC firm **3** rounds [Canaan](https://millionrounds.com/fund/canaan-partners) VC firm **2** rounds [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) VC firm **1** round [Redmile Group](https://millionrounds.com/fund/redmile-group) VC firm **1** round [Arch](https://millionrounds.com/fund/arch) Hedge fund **1** round [Alexandria Real Estate](https://millionrounds.com/fund/alexandria-real-estate) Growth equity **1** round [Helsinn](https://millionrounds.com/fund/helsinn) VC firm **1** round [Baxalta](https://millionrounds.com/fund/baxalta-ventures) Corporate VC **1** round HT Family Office no record of our own yet **1** round Marsh Rice University no record of our own yet **1** round MD Anderson no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=oncoresponse). ## Quick answers about OncoResponse ### Who invested in OncoResponse? OncoResponse's investors include GreatPoint Ventures, Canaan, ARCH Venture Partners, Redmile Group and Arch, and 6 more on record. ### How much has OncoResponse raised? OncoResponse has raised $44M across 3 rounds since 2016. ### When did OncoResponse last raise? OncoResponse's most recent round was a Series D of $14M in May 2023. ### What was OncoResponse's biggest round? OncoResponse's largest round on record is $23M (Series A), in Mar 2017. ### Who backed OncoResponse first? OncoResponse's first round on record, in Oct 2016, was backed by GreatPoint Ventures. ### What stage is OncoResponse at? OncoResponse's latest named round is a Series D, in May 2023. ### Where is OncoResponse based? OncoResponse is based in the United States. ## Companies like OncoResponse In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app